Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by TOSHIYUKI KAMEYAMA
Anisomycin and New Congeners Active Against Human Tumor Cell Lines.
Journal of Antibiotics
Drug Discovery
Pharmacology
Related publications
Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines
PLoS ONE
Multidisciplinary
Toxicological Evaluation of Occidiofungin Against Mice and Human Cancer Cell Lines
Pharmacology & Pharmacy
Comparison of HLA-G and MMP Transcription in Human Tumor Cell Lines
Neoplasma
Cancer Research
COTI-2, a Novel Small Molecule That Is Active Against Multiple Human Cancer Cell Lines in Vitro and in Vivo
Oncotarget
Oncology
Rifamycin Congeners Kanglemycins Are Active Against Rifampicin-Resistant Bacteria via a Distinct Mechanism
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Cytocidal Activities of Topoisomerase 1 Inhibitors and 5-Azacytidine Against Pheochromocytoma/Paraganglioma Cells in Primary Human Tumor Cultures and Mouse Cell Lines
PLoS ONE
Multidisciplinary
Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-Orl, With Increased Cytotoxicity Against Human Tumor Cell Lines
Four New Human Renal Cell Carcinoma Cell Lines Expressing Globo-Series Gangliosides.
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
WARNING: G‐401 and SK‐NEP‐1 Cell Lines Are Not Wilms Tumor Cell Lines
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
